back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-18 07:41 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,545
+296 vol $5.22 each |
109,663 | |
| Filed 2026-06-18 07:40 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,505
+695 vol $9.36 each |
109,367 | |
| Older filings | ||||||
| Filed 2026-03-27 16:44 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$338,234
+53,688 vol $6.30 each |
160,186 | |
| Filed 2026-03-27 16:39 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$932,456
+148,009 vol $6.30 each |
951,388 | |
| Filed 2026-03-27 16:36 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$235,990
+36,816 vol $6.41 each |
108,672 | |
| Filed 2026-03-27 16:33 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-103,469.76
-23,304 vol $4.44 each |
106,498 | |
| Filed 2026-03-27 16:27 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-74,689.32
-11,652 vol $6.41 each |
0 | |
| Filed 2026-03-23 17:20 Tx date 2026-03-19 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-225,405.96
-29,388 vol $7.67 each |
803,379 | |
| Filed 2026-03-20 15:32 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,293
+244 vol $5.30 each |
71,856 | |
| Filed 2026-03-20 15:31 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,503
+1,054 vol $6.17 each |
71,612 | |
| Filed 2025-12-19 14:07 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,294
+249 vol $5.20 each |
70,558 | |
| Filed 2025-12-19 14:06 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,500
+1,078 vol $6.03 each |
70,309 | |
| Filed 2025-09-17 15:45 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,295
+293 vol $4.42 each |
69,231 | |
| Filed 2025-09-17 15:43 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,010
+2,036 vol $6.39 each |
68,938 | |
| Filed 2025-07-11 16:21 Tx date 2025-04-03 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-216,362.70
-27,990 vol $7.73 each |
832,767 | |
| Filed 2025-07-10 15:43 Tx date 2025-03-20 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-216,362.70
-27,990 vol $7.73 each |
||
| Filed 2025-07-10 15:43 Tx date 2025-03-20 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-216,362.70
-27,990 vol $7.73 each |
672,213 | |
| Filed 2025-06-18 16:24 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,293
+263 vol $4.92 each |
66,902 | |
| Filed 2025-06-18 16:23 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,010
+2,154 vol $6.04 each |
66,639 | |
| Filed 2025-04-09 16:43 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$122,579
+19,867 vol $6.17 each |
64,485 | |